Voiding Dysfunction Clinical Trial
Official title:
The Measurement of Bladder Impedance and Heart Rate During Urodynamic Study - Prospective Study
Purpose To measure the impedance of the bladder during the urodynamic study to see if changes
in the impedance value occur as the bladder volume changes in pediatric patients aged 5-12
years along with its leg time.
In addition, during the urodynamics test, the heart rate is measured at the same time to
confirm the pulse change due to the filling of the bladder.
-Background of the study (Method of identifying urinary bladder using impedance) In order to
overcome the limitation of the method of checking the urinary volume in the bladder using
ultrasound, the measurement of the impedance in the bladder is proposed as an alternative.
Impedance measurement is non-invasive, very low cost, easy to measure and has a great
advantage that it can be continuously measured in everyday life. In fact, early studies
suggest that impedance measurement in the bladder is helpful in identifying urinary bladder
capacity.
On the other hand, there are two disadvantages to the urinary bladder identification method
using impedance. One is the relative aspect that the impedance value changes according to the
patient, and the other is the time lag time from the measurement point to the point when the
impedance change appears.
- In order to overcome this problem of impedance-based urinary bladder identification
method, we measured impedance change according to real-time change of urinary volume in
bladder during urodynamic study.
- Background of the Invention (Pulse changes due to changes in urinary volume in bladder)
It is known that when the urine enters the urinary bladder, the autonomic nervous system
detects and regulates the heart rhythm, and the change of heart rate has not been
reported in pediatric patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05439902 -
Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women
|
N/A | |
| Terminated |
NCT00713908 -
Voiding Dysfunction in the Postoperative Period Following Placement of the TVT
|
N/A | |
| Completed |
NCT00679315 -
Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female
|
Phase 2 | |
| Completed |
NCT00719589 -
Outcomes of Pudendal InterStim
|
N/A | |
| Completed |
NCT01189136 -
Treatment for Acute Postoperative Voiding Dysfunction
|
N/A | |
| Completed |
NCT00214045 -
Rigid Versus Flexible Cystoscopy in Women
|
N/A | |
| Completed |
NCT05820139 -
Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery
|
N/A | |
| Completed |
NCT03574610 -
Brain Targets in Patients With Bladder Emptying Difficulties
|
N/A | |
| Recruiting |
NCT00839969 -
Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
|
N/A | |
| Completed |
NCT01154946 -
Clinical Implication of DAC (Detrusor After-contraction)
|
N/A | |
| Completed |
NCT01197248 -
Randomized Controlled Trial of Cystocele Plication Risks ("CPR Trial"): A Pilot Study
|
Phase 2 | |
| Recruiting |
NCT03913819 -
Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction
|
||
| Withdrawn |
NCT02297178 -
A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
|
N/A | |
| Not yet recruiting |
NCT06404996 -
Smart-phone Application Versus Conventional Paper for the Documentation of Voiding Dysfunction in Children
|
N/A | |
| Completed |
NCT05295823 -
Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound
|
N/A | |
| Active, not recruiting |
NCT02193451 -
Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods
|
N/A | |
| Completed |
NCT01228370 -
Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder
|
Phase 4 |